Hebei Ronglin Pharmaceutical

Hebei Ronglin Pharmaceutical is a pharmaceutical manufacturing company based in Shijiazhuang, Hebei Province, China. Established in 2011, the company specializes in the research, development, and production of chemical drugs, including both active pharmaceutical ingredients (APIs) and finished oral solid dosage forms. Its product portfolio is primarily focused on chronic disease management, specifically targeting cardiovascular health and metabolic disorders such as hypertension and type 2 diabetes. The company operates modern, GMP-certified facilities designed to meet domestic and international quality standards. Hebei Ronglin Pharmaceutical plays a key role in the regional pharmaceutical industrial cluster, providing essential generic medications to the healthcare market.